Cell Lines with Targeted Deletions of SMAD4

Creation of cell lines in which the SMAD4 genes have been disrupted by targeted homologous interation. Description (Set) Proposed Use (Set) Isogenic cell lines with or without intact SMAD4 genes are valuable reagents for studying the cellular effects of TGF-b family members and for discovering drugs that may modulate this pathway.

Inventor(s): Vogelstein, Bert

Type of Offer: Licensing

Next Patent »
« More Medical Patents

Share on      

CrowdSell Your Patent